Home > Boards > US Listed > Medical - Drugs >

Bionomics: BNOEF (BNOEF)

BNOEF RSS Feed
Add BNOEF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/28/2019 9:19:14 AM - Followers: 1 - Board type: Free - Posts Today: 0

https://www.bionomics.com.au/

Bionomics Ltd

From Companies website
About:

Message from the Chairman

Bionomics is a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders such as anxiety, depression and Alzheimer's disease.

I invite you to spend a few minutes exploring our website and getting to know us. Our exceptionally talented team is driven by a shared commitment to make a difference in diseases with high unmet need and inadequate treatment options.

We are in a strong growth phase with our world-class portfolio of promising drug candidates from early to mid stages of clinical development. This portfolio is fed by highly productive drug discovery platforms that include MultiCore®, our proprietary chemistry capability.

At the core of our business is strategic partnering. We partner with large pharmaceutical companies to get our drugs through the later stages of development and into the market as rapidly as possible. This means we can focus our strengths in innovative drug discovery to extract as many "shots on goal" from our diverse pipeline in the quest to create the world's new blockbuster drugs.

We have a passion for what we do and we work with the best in the world to deliver meaningful outcomes from our discoveries. We look forward to you accompanying us on this extremely valuable journey.

 

Dr Errol DeSouza PhD

Board of Directors

Dr Errol De Souza - Executive Chairman

Mr Peter Turner - Non-Executive Director

Mr David Wilson - Non-Executive Director

Mr Alan Fisher - Non-Executive Director

Mr Mitchell Kaye - Non-Executive Director


(BNOEF)

0.0120 +0.0015 (+14.29%) 10:56 ET [OTC US]
 
Quote Overview for Wed, Jul 10th, 2019
BNOEF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BNOEF News: Bionomics Initiates Phase II Clinical Trial of BNC210 for Treatment of Anxiety 04/20/2015 06:00:00 AM
BNOEF News: BNC105 Biomarker Data to Be Presented at Asian Oncology Conference 04/10/2015 06:00:00 AM
BNOEF News: OTC Markets Group Welcomes Bionomics to OTCQX® 03/02/2015 07:00:00 AM